Detalhe da pesquisa
1.
A 2-Year Observational Study in Patients Suffering from Idiopathic Pulmonary Fibrosis and Treated with Pirfenidone: A French Ancillary Study of PASSPORT.
Respiration
; 98(1): 19-28, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-30965332
2.
Comparison of antidepressant classes and the risk and time course of suicide attempts in adults: propensity matched, retrospective cohort study.
Br J Psychiatry
; 208(3): 271-9, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26635328
3.
Treatment with duloxetine in adults and the incidence of cardiovascular events.
J Clin Psychopharmacol
; 32(1): 23-30, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22198454
4.
Duloxetine for depression and the incidence of hepatic events in adults.
J Clin Psychopharmacol
; 31(4): 517-22, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21694615
5.
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study.
ERJ Open Res
; 4(4)2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-30364407
6.
An Open-Label, Phase II Study of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (PIPF-002).
Pulm Ther
; 4(1): 59-71, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-32026243
7.
Ecological studies of antidepressant treatment and suicidal risks.
Harv Rev Psychiatry
; 15(4): 133-45, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-17687708
8.
Hepatic effects of duloxetine-II: spontaneous reports and epidemiology of hepatic events.
Curr Drug Saf
; 3(2): 143-53, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18690992
9.
Hepatic effects of duloxetine-III: analysis of hepatic events using external data sources.
Curr Drug Saf
; 3(2): 154-62, 2008 May.
Artigo
Inglês
| MEDLINE | ID: mdl-18690993
10.
Answers to the most common questions about the hepatic safety profile of duloxetine.
Postgrad Med
; 120(2): 111-8, 2008 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-18654076
11.
Socioeconomic risk factors for breast cancer: distinguishing individual- and community-level effects.
Epidemiology
; 15(4): 442-50, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15232405